Get the latest Science News and Discoveries

First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials

Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment for the neurodegenerative retinal disease known as MacTel. For individuals with macular telangiectasia type 2 (MacTel), a rare retinal disease that steadily

None

Get the Android app